banner
ROCK inhibitor GSK 269962, Purity ≥98%
1-631-637-6119

Cat. No.: X24-05-ZQ849

ROCK inhibitor GSK 269962, Purity ≥98%

Synonym: 850664-21-0; GSK269962; GSK-269962; GSK269962A; GSK-269962A; ROCK inhibitor

  • CAS Number: 850664-21-0
  • Compound CID: 16095342
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
Datasheet
MSDS
MSDS
Properties
Description
GSK 269962 blocks the ATP-binding site of ROCK, thereby inhibiting its kinase activity. It targets AKT1, AKT2, AKT3, and CDK2.
Molecular Weight
570.6
Molecular Formula
C29H30N8O5
Targets
AKT1: 955 nM; AKT2: 1350 nM; AKT3: 1510 nM; CDK2: 3500 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
GSK 269962 is utilized to study its inhibitory effects on Rho-associated protein kinases (ROCK1/2) in cell mobility research.
Related Products
PRODUCTS
Online Inquiry

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Important Links

Contact Us

  • SUITE 201, 17 Ramsey Road, Shirley, NY 11967, USA
  • 1-631-637-6119
Copyright © 2025 CD BioGlyco. All rights reserved.
0
There is no product in your cart.

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x